- Home
- NESR vs RXST Comparison
NESR vs RXST Comparison
Compare NESR & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NESR
- RXST
- Stock Information
- Founded
- NESR 2017
- RXST 1997
- Country
- NESR United States
- RXST United States
- Employees
- NESR N/A
- RXST N/A
- Industry
- NESR
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NESR
- RXST Health Care
- Exchange
- NESR NYSE
- RXST Nasdaq
- Market Cap
- NESR N/A
- RXST 1.0B
- IPO Year
- NESR N/A
- RXST 2021
- Fundamental
- Price
- NESR $8.07
- RXST $24.78
- Analyst Decision
- NESR Strong Buy
- RXST Strong Buy
- Analyst Count
- NESR 4
- RXST 9
- Target Price
- NESR $15.00
- RXST $49.33
- AVG Volume (30 Days)
- NESR 248.0K
- RXST 615.4K
- Earning Date
- NESR 03-12-2025
- RXST 05-05-2025
- Dividend Yield
- NESR N/A
- RXST N/A
- EPS Growth
- NESR 514.84
- RXST N/A
- EPS
- NESR 0.80
- RXST N/A
- Revenue
- NESR $1,301,704,000.00
- RXST $139,927,000.00
- Revenue This Year
- NESR $10.16
- RXST $38.53
- Revenue Next Year
- NESR $7.46
- RXST $24.60
- P/E Ratio
- NESR $10.13
- RXST N/A
- Revenue Growth
- NESR 13.60
- RXST 57.09
- 52 Week Low
- NESR $7.29
- RXST $24.09
- 52 Week High
- NESR $9.89
- RXST $66.54
- Technical
- Relative Strength Index (RSI)
- NESR N/A
- RXST 31.28
- Support Level
- NESR N/A
- RXST $24.09
- Resistance Level
- NESR N/A
- RXST $25.50
- Average True Range (ATR)
- NESR 0.00
- RXST 1.03
- MACD
- NESR 0.00
- RXST 0.12
- Stochastic Oscillator
- NESR 0.00
- RXST 19.39
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.